Want to see ENSG full AI Analyst Report?
ENSG Stock Chart & Stats
$172.99
$4.74(2.74%)
At close: 4:00 PM EDT
$172.99
$4.74(2.74%)
Day’s Range― - ―
52-Week Range$141.58 - $218.00
Previous CloseN/A
Volume433.07K
Average Volume (3M)891.21K
Market Cap
$10.64B
Enterprise Value$11.47K
Total Cash (Recent Filing)$320.84M
Total Debt (Recent Filing)$2.25B
Price to Earnings (P/E)27.8
Beta0.16
Next Earnings
Feb 10, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)6.57
Shares Outstanding58,282,433
10 Day Avg. Volume454,074
30 Day Avg. Volume891,208
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)4.47
Price to Sales (P/S)1.97
P/FCF Ratio26.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$217.50Price Target Upside25.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.75
Revenue Forecast (FY)$5.90B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue And Earnings GrowthDouble-digit revenue and earnings growth indicates strong demand, improving operating execution and continued capacity to expand through organic performance and acquisitions over the next several quarters.
Clinical Quality And Operating DifferentiationSuperior clinical outcomes and quality ratings can support referrals, occupancy, payer relationships and reimbursement resilience, creating a durable advantage in a highly regulated and labor-intensive care market.
Strong Liquidity And Acquisition CapacityHealthy cash generation and substantial liquidity give Ensign flexibility to fund facility investments, absorb integration costs and pursue additional operations while maintaining manageable leverage.
Bears Say
Margin CompressionLower margins than earlier periods suggest persistent labor, operating or reimbursement pressure. Even with resilient earnings, further cost inflation could limit the conversion of revenue growth into durable profit growth.
Acquisition Integration And Turnaround RiskEnsign’s acquisition strategy expands its growth opportunity but also creates execution risk. Delayed turnarounds, onboarding demands or weaker-than-expected occupancy could weigh on margins and returns for several quarters.
Reimbursement And Regulatory ExposureDependence on government and managed-care reimbursement leaves the business exposed to policy changes, rating methodology shifts and state budget pressure, which can affect referrals, revenue rates and facility economics.
The Ensign Group News
ENSG FAQ
What was The Ensign’s price range in the past 12 months?
The Ensign lowest stock price was $141.58 and its highest was $218.00 in the past 12 months.
What is The Ensign’s market cap?
The Ensign’s market cap is $10.64B.
When is The Ensign’s upcoming earnings report date?
The Ensign’s upcoming earnings report date is Feb 10, 2027 which is in 173 days.
How were The Ensign’s earnings last quarter?
The Ensign released its earnings results on Jul 27, 2026. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.848 by $0.072.
Is The Ensign overvalued?
According to Wall Street analysts The Ensign’s price is currently Undervalued.
Does The Ensign pay dividends?
The Ensign pays a Quarterly dividend of $0.065 which represents an annual dividend yield of 0.14%. See more information on The Ensign dividends here
What is The Ensign’s EPS estimate?
The Ensign’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does The Ensign have?
The Ensign has 58,282,433 shares outstanding.
What happened to The Ensign’s price movement after its last earnings report?
The Ensign reported an EPS of $1.92 in its last earnings report, beating expectations of $1.848. Following the earnings report the stock price went up 2.937%.
Which hedge fund is a major shareholder of The Ensign?
Currently, no hedge funds are holding shares in ENSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The Ensign Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$217.50 (25.73% Upside)
$217.50 (25.73% Upside)
Blogger Sentiment
Neutral
ENSG Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 257.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.74%
12-Months-Change
Fundamentals
Return on Equity
0.14%
Trailing 12-Months
Asset Growth
16.61%
Trailing 12-Months
Company Description
The Ensign
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
ENSG Company Deck
ENSG Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized broad operational and financial momentum — double-digit revenue and earnings growth, raised full-year guidance, strong liquidity and demonstrable clinical outperformance across multiple metrics. Management acknowledged near-term integration challenges from recent acquisitions (notably Texas assets), exposure to CMS methodology changes and typical reimbursement/regulatory risks, but portrayed confidence in the leadership-driven transition model and balance sheet capacity to execute. Overall, the positives — durable clinical advantages, robust organic and acquisition-driven growth, tightened leverage and improved occupancy/skilled mix — materially outweigh the cited lowlights.View all ENSG earnings summariesENSG Stock 12 Month Forecast
Average Price Target
$217.50
▲(25.73% Upside)
Technical Analysis
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Surgery Partners
―
Ownership Overview
1.56% Insiders
33.73% Mutual Funds
30.67% Other Institutional Investors
13.36% Public Companies and
Individual Investors